Stem Cell Proliferation via DANCE Gene Marker and Growth Factors
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for improving the proliferative ability of mesenchymal stem cells in vitro are limited by the complexity of maintaining optimal environmental conditions and the low proliferative capability of somatic cells, necessitating a more effective approach to select and enhance stem cells with high proliferative potential.
Innovation Solution
A marker detection composition and method utilizing the DANCE gene expression level to assess and enhance the proliferative ability of stem cells, involving the measurement of DANCE gene or protein expression levels using mRNA or protein analysis techniques, and administering DANCE protein or gene to improve stem cell culture conditions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If mesenchymal stem cells are cultured in vitro to improve proliferative ability, then cell proliferation can be enhanced, but environmental conditions must be precisely controlled which increases system complexity
Solution Approach 1:
The patent changes the biochemical parameter of the culture medium by adding specific growth factors (EGF at 20 ng/mL, FGF-basic at 20 ng/mL, IGF-1 at 20 ng/mL) to optimize cell proliferation. This approach enhances proliferative ability through controlled parameter adjustment rather than complex environmental control systems.
2Reliability
If somatic cells are used for cell therapy, then ethical problems are avoided, but proliferative capability is low which limits practical application
Solution Approach 1:
The patent applies parameter changes by introducing specific growth factors into the culture medium to enhance the proliferative capability of somatic cells (mesenchymal stem cells). This allows somatic cells to achieve higher proliferation rates while maintaining their ethical advantages, resolving the contradiction between ethical acceptability and proliferative capability.
3Productivity
If embryo-derived pluripotent stem cells are used, then high proliferative ability is achieved, but ethical problems and genetic instability arise
Solution Approach 1:
Instead of using embryo-derived cells to achieve high proliferation, the patent inverts the approach by enhancing the proliferation of adult somatic cells (mesenchymal stem cells) through growth factor supplementation. This reversal allows achieving high proliferative ability while maintaining genetic stability and avoiding ethical issues associated with embryonic cells.
4Stability of the object's composition
If in vitro culture conditions are optimized for mesenchymal stem cells, then proliferative properties are maintained, but the complexity of adjusting nutrients, pH, temperature, and osmotic pressure increases
Solution Approach 1:
The patent simplifies the complex environmental control by focusing on changing the biochemical composition parameter - specifically adding defined concentrations of growth factors (EGF, FGF-basic, IGF-1) to the culture medium. This approach maintains proliferative properties while reducing the complexity of controlling multiple physical parameters like pH, temperature, and osmotic pressure.
Data Source
AI summary
The present application relates to a marker gene for detecting the proliferative ability of stem cells and uses thereof, and provides a marker detection composition for detecting the proliferative ability of stem cells, a kit for detecting the proliferative ability of stem cells, and a composition for improving the proliferative ability of stem cells, etc. According to the composition or method according to an aspect, stem cells having a high proliferative ability may be easily selected, and the proliferative ability of stern cells may be significantly improved.